Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers.

Abstract

Colorectal adenocarcinoma (COAD) is one subtype of colorectal carcinoma (CRC), whose development is associated with genetics, inappropriate immune response, and environmental factors. Although significant advances have been made in the treatment of COAD, the mortality rate remains high. It is a pressing need to explore novel therapeutic targets of COAD. Available evidence indicated that immune cell infiltration was correlated with cancer prognosis. To reveal the roles of immune cells in the COAD prognosis, a study published in Bioscience Reports by Li et al. (Bioscience Reports (2021) 41, https://doi.org/10.1042/BSR20203496) analyzed data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) dataset. It demonstrated a beneficial effect of Th17 cells in COAD prognosis. In addition, six hub genes (KRT23, ULBP2, ASRGL1, SERPINA1, SCIN, and SLC28A2) were identified to correlate with Th17 cells and COAD prognosis, suggesting one new therapy strategy and some predictive biomarkers of COAD. These findings reported by Li et al. may pave one way to explore the molecular mechanism of COAD further.

• Authors: Kexin Chen, Zhen Zeng, Chunxiang Ma, Yuan Dang, Hu Zhang
• Journal: Bioscience reports (Biosci Rep) Vol. 41 Issue 12 (12 22 2021) ISSN: 1573-4935 [Electronic] England
• PMID: 34850851 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Comment)
• Copyright: © 2021 The Author(s).

Chemical References

• Biomarkers, Tumor

Topics

• Adenocarcinoma (genetics)
• Biomarkers, Tumor (genetics)
• Colorectal Neoplasms (genetics)
• Gene Expression Regulation, Neoplastic
• Humans
• Prognosis